verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 180 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-405
Product ID 71610-405_335e56e6-a09f-488d-84dc-06f0b50950df
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206173
Listing Expiration 2026-12-31
Marketing Start 2019-05-15

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610405
Hyphenated Format 71610-405

Supplemental Identifiers

RxCUI
897640
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA206173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (71610-405-60)
  • 180 TABLET in 1 BOTTLE (71610-405-80)
source: ndc

Packages (2)

71610-405-60 90 TABLET in 1 BOTTLE (71610-405-60) 71610-405-80 180 TABLET in 1 BOTTLE (71610-405-80)

Ingredients (1)

verapamil hydrochloride (180 mg/1)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "335e56e6-a09f-488d-84dc-06f0b50950df", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["2712ab16-122b-4f44-a687-e2cb3c04019e"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-405-60)", "package_ndc": "71610-405-60", "marketing_start_date": "20200318"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-405-80)", "package_ndc": "71610-405-80", "marketing_start_date": "20200318"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71610-405_335e56e6-a09f-488d-84dc-06f0b50950df", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-405", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}